Andrew Volosov

424 total citations
14 papers, 376 citations indexed

About

Andrew Volosov is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Andrew Volosov has authored 14 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Andrew Volosov's work include Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Andrew Volosov is often cited by papers focused on Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Andrew Volosov collaborates with scholars based in Israel, United States and Italy. Andrew Volosov's co-authors include Steven J. Soldin, Kimberly L. Napoli, Meir Bialer, Emilio Perucca, Steven J. Soldin, Lillian Ting, Christopher W. Alexander, B. Yagen, Boris Yagen and Amnon Sintov and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Epilepsia and Clinical Pharmacology & Therapeutics.

In The Last Decade

Andrew Volosov

13 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Volosov Israel 10 155 114 81 69 63 14 376
Yasuaki Mino Japan 14 90 0.6× 49 0.4× 113 1.4× 115 1.7× 60 1.0× 33 459
T. Pawiński Poland 13 146 0.9× 139 1.2× 108 1.3× 465 6.7× 178 2.8× 45 766
Kosei NODA Japan 11 117 0.8× 25 0.2× 49 0.6× 137 2.0× 55 0.9× 32 435
Joelle Campestrini United States 16 96 0.6× 74 0.6× 11 0.1× 91 1.3× 64 1.0× 29 776
Anisha E. Mendonza United States 10 77 0.5× 40 0.4× 40 0.5× 117 1.7× 77 1.2× 20 320
Kenji Ohtsubo Japan 9 194 1.3× 58 0.5× 66 0.8× 14 0.2× 33 0.5× 24 483
Evan T. Ogburn United States 11 86 0.6× 23 0.2× 196 2.4× 15 0.2× 126 2.0× 11 567
Fumio Itagaki Japan 13 81 0.5× 38 0.3× 18 0.2× 57 0.8× 123 2.0× 30 470
C Vidal Germany 11 84 0.5× 12 0.1× 67 0.8× 226 3.3× 116 1.8× 16 463
P Riant France 12 69 0.4× 30 0.3× 26 0.3× 16 0.2× 92 1.5× 26 362

Countries citing papers authored by Andrew Volosov

Since Specialization
Citations

This map shows the geographic impact of Andrew Volosov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Volosov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Volosov more than expected).

Fields of papers citing papers by Andrew Volosov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Volosov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Volosov. The network helps show where Andrew Volosov may publish in the future.

Co-authorship network of co-authors of Andrew Volosov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Volosov. A scholar is included among the top collaborators of Andrew Volosov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Volosov. Andrew Volosov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sikes, Carolyn R., et al.. (2019). An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children. Journal of Child and Adolescent Psychopharmacology. 30(1). 15–20. 1 indexed citations
2.
Sikes, Carolyn R., et al.. (2019). 6.66 A PHASE 4, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF A NOVEL METHYLPHENIDATE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLET FORMULATION IN PRESCHOOL-AGED CHILDREN. Journal of the American Academy of Child & Adolescent Psychiatry. 58(10). S292–S292.
3.
Riesenberg, Robert, et al.. (2018). 2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children. Journal of the American Academy of Child & Adolescent Psychiatry. 57(10). S173–S174. 1 indexed citations
4.
Evans, Jilly F., Jeremy Kintigh, Emily Hill, et al.. (2007). Novel, Acidic CCR2 Receptor Antagonists: Lead Optimization. Letters in Drug Design & Discovery. 4(4). 263–271. 21 indexed citations
5.
Burton, Maggi, Philippe Collart, Mária Eckert, et al.. (2007). Discovery of new C3aR ligands. Part 2: Amino-piperidine derivatives. Bioorganic & Medicinal Chemistry Letters. 17(12). 3262–3265. 13 indexed citations
6.
Volosov, Andrew, Christopher W. Alexander, Lillian Ting, & Steven J. Soldin. (2002). Simple rapid method for quantification of antiretrovirals by liquid chromatography—tandem mass-spectrometry. Clinical Biochemistry. 35(2). 99–103. 72 indexed citations
7.
Volosov, Andrew, Kimberly L. Napoli, & Steven J. Soldin. (2001). Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography—tandem mass-spectrometry. Clinical Biochemistry. 34(4). 285–290. 97 indexed citations
8.
9.
Volosov, Andrew, et al.. (2000). Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 738(2). 419–425. 37 indexed citations
10.
Volosov, Andrew, Amnon Sintov, & Meir Bialer. (1999). Stereoselective Pharmacokinetic Analysis of the Antiepileptic 10-Hydroxycarbazepine in Dogs. Therapeutic Drug Monitoring. 21(2). 219–223. 10 indexed citations
11.
Volosov, Andrew, et al.. (1999). Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clinical Pharmacology & Therapeutics. 66(6). 547–553. 85 indexed citations
12.
Volosov, Andrew & Meir Bialer. (1999). Use of mean residence time to determine the magnitude of difference between rate constants and to calculatetmax in the Bateman equation. Biopharmaceutics & Drug Disposition. 20(1). 3–9. 1 indexed citations
13.
Volosov, Andrew, et al.. (1999). Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clinical Pharmacology & Therapeutics. 66(6). 547–553. 9 indexed citations
14.
Bialer, Meir, Lidia Arcavi, Andrew Volosov, et al.. (1998). Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine. Epilepsy Research. 32(3). 371–378. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuaki Mino Breakdown of academic impact, for papers by T. Pawiński Breakdown of academic impact, for papers by Kosei NODA Breakdown of academic impact, for papers by Joelle Campestrini Breakdown of academic impact, for papers by Anisha E. Mendonza Breakdown of academic impact, for papers by Kenji Ohtsubo Breakdown of academic impact, for papers by Evan T. Ogburn Breakdown of academic impact, for papers by Fumio Itagaki Breakdown of academic impact, for papers by C Vidal Breakdown of academic impact, for papers by P Riant
Rankless by CCL
2026